Why is drug pricing so confusing?
AJ explained, “When you look at the last hop in the [pharmaceutical]supply chain, nothing makes sense. It looks like the price of a drug changes every hour of every day for every patient for every drug. And the reality is, and I've said this a thousand times, drug prices in the U.S. are incredibly stable.”
While vertical integration has some merits, the concept “I can mark up a drug to be anything to create higher profit margin and economics” is what's unethical.
AJ and Arundhati explored several key issues in ~20 minutes, including the "awesome responsibility" administrators share with [health plan] fiduciaries, sophisticated payers becoming more aware of and receptive to aligned models, and how pharmaceutical manufacturers lost control of the supply chain, to name a few.
Watch the full replay below!
CONTACT US for more information on Capital Rx's ethical, aligned PBM model.